Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands (Q48682139)

14 February 2018

title

Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands (English)

1 reference

14 February 2018

1 reference

Ault DT

1

1 reference

14 February 2018

Werling LL

series ordinal

2

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

published in

Brain Research

1 reference

14 February 2018

volume

760

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

210-217

1 reference

14 February 2018

Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Purification, molecular cloning, and expression of the mammalian sigma1-binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Neuropeptide Y and sigma receptor agonists act through a common pathway to stimulate duodenal alkaline secretion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Activation and desensitization of N-methyl-D-aspartate receptors in nucleated outside-out patches from mouse neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Neuropeptide Y and peptide YY do not bind to brain σ and phencyclidine binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Synthesis of receptor antagonists of neuropeptide Y

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Neuropeptide Y receptor subtypes, Y1 and Y2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900283-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(97)00283-7

1 reference

14 February 2018

1 reference

14 February 2018